Clinical Trial Detail
| NCT ID | NCT03175224 |
| Title | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Apollomics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |
CKB BOOST